June 12, 2017 / 9:04 AM / a month ago

BRIEF-Anhui Anke Biotechnology Group receives patent

1 Min Read

June 12(Reuters) - Anhui Anke Biotechnology Group Co Ltd :

* Says it received patent(No. ZL 2014 1 0027089.0) for preparation technology for improving native conformation content of recombinant human interferon alpha2b, valid for 20 years

Source text in Chinese: goo.gl/TJ9Mmp

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below